Immunicum AB (publ) Announces Advancement to Next Dosage Group Level in Phase Ib/II ILIAD Combination Trial

NEXT STORY
Translate Bio Announces Upcoming MRT5005 Presentations at the 33rd Annual North American Cystic Fibrosis Conference
PREV STORY
Note from Chairman of BriaCell Therapeutics – October is Breast Cancer Awareness Month
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Journal of Clinical Oncology Publishes Clinical Data for Cohort 2 in Iovance C-144-01 Study of Lifileucel TIL Therapy in Metastatic Melanoma

author_avatar
NASDAQ Market News

Bioxytran Using Paradigm Changing Vital Sign that Can Measure Real Time Tissue Oxygen Balance in Emergency Medicine

author_avatar
NASDAQ Market News

The results from Oasmia Pharmaceuticals first study with paclitaxel micellar in humans are published in the scientific journal ”Advances in Therapy”.

author_avatar
NASDAQ Market News